CYRS-1542

N/A

Report date: 2023/07/21 18:10:02
NME

Base Information

Drug NameCYRS-1542
Drug Alias NameCYRS-1542CYRS1542
ClassificationSmall molecules
Mechanisms of ActionGlutathione S-transferase Pi modulators
TargetsGlutathione S-transferase Pi
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCyrus Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A